Wells Fargo & Company Reata Pharmaceuticals Inc Transaction History

Wells Fargo & Company

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 15, 2023	BUY	$79.22 - $105.37 $464,783 - $618,205	5,867 Added 84.83%	12,783 $1.3 Million
Q1 2023 May 12, 2023	BUY	$30.85 - $93.17 $186,765 - $564,051	6,054 Added 702.32%	6,916 $628,000
Q4 2022 Feb 13, 2023	SELL	$22.15 - $42.11 $2,945 - $5,600	-133 Reduced 13.37%	862 $32,000
Q3 2022 Nov 14, 2022	SELL	$19.41 - $36.49 $21,952 - $41,270	-1,131 Reduced 53.2%	995 $25,000
Q2 2022 Aug 12, 2022	SELL	$20.71 - $36.5 $164,768 - $290,394	-7,956 Reduced 78.91%	2,126 $65,000
Q1 2022 May 16, 2022	SELL	$24.12 - $39.6 $428,443 - $703,414	-17,763 Reduced 63.79%	10,082 $330,000
Q4 2021 Feb 14, 2022	BUY	$25.61 - $110.96 $226,033 - $979,332	8,826 Added 46.41%	27,845 $734,000
Q3 2021 Nov 15, 2021	BUY	$100.0 - $143.02 $408,100 - $583,664	4,081 Added 27.32%	19,019 $1.91 Million
Q2 2021 Aug 16, 2021	BUY	$78.27 - $151.29 $375,382 - $725,586	4,796 Added 47.29%	14,938 $2.11 Million
Q1 2021 May 13, 2021	SELL	$94.25 - $132.81 $33,647 - $47,413	-357 Reduced 3.4%	10,142 $1.01 Million
Q4 2020 Feb 09, 2021	SELL	$102.03 - $184.62 $250,075 - $452,503	-2,451 Reduced 18.93%	10,499 $1.3 Million
Q3 2020 Nov 05, 2020	BUY	$93.53 - $163.34 $467,462 - $816,373	4,998 Added 62.85%	12,950 $1.26 Million
Q2 2020 Aug 13, 2020	SELL	$126.3 - $176.56 $948,765 - $1.33 Million	-7,512 Reduced 48.58%	7,952 $1.24 Million
Q1 2020 May 14, 2020	BUY	$124.16 - $247.74 $1.92 Million - $3.83 Million	15,464 New	15,464 $2.23 Million

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.